These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1176 related articles for article (PubMed ID: 18936575)
1. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575 [TBL] [Abstract][Full Text] [Related]
2. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294 [TBL] [Abstract][Full Text] [Related]
3. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218 [TBL] [Abstract][Full Text] [Related]
4. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395 [TBL] [Abstract][Full Text] [Related]
5. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585 [TBL] [Abstract][Full Text] [Related]
6. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. Bharat A; Brown DB; Crippin JS; Gould JE; Lowell JA; Shenoy S; Desai NM; Chapman WC J Am Coll Surg; 2006 Oct; 203(4):411-20. PubMed ID: 17000383 [TBL] [Abstract][Full Text] [Related]
7. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Wong LL; Tanaka K; Lau L; Komura S Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041 [TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284 [TBL] [Abstract][Full Text] [Related]
9. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection. Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326 [TBL] [Abstract][Full Text] [Related]
10. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y; Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600 [TBL] [Abstract][Full Text] [Related]
11. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158 [TBL] [Abstract][Full Text] [Related]
12. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Otto G; Herber S; Heise M; Lohse AW; Mönch C; Bittinger F; Hoppe-Lotichius M; Schuchmann M; Victor A; Pitton M Liver Transpl; 2006 Aug; 12(8):1260-7. PubMed ID: 16826556 [TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846 [TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria. Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412 [TBL] [Abstract][Full Text] [Related]
16. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes. Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530 [TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579 [TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma. Otto G; Heise M; Moench C; Herber S; Bittinger F; Schuchmann M; Hoppe-Lotichius M; Pitton M Transplant Proc; 2007 Mar; 39(2):537-9. PubMed ID: 17362776 [TBL] [Abstract][Full Text] [Related]